These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14573851)

  • 21. The responsibilities of growing up.
    Nat Biotechnol; 2006 Mar; 24(3):225. PubMed ID: 16525362
    [No Abstract]   [Full Text] [Related]  

  • 22. Rainbow biotech--South Africa's emerging sector.
    Louët S
    Nat Biotechnol; 2006 Nov; 24(11):1313-6. PubMed ID: 17093464
    [No Abstract]   [Full Text] [Related]  

  • 23. Should moral objections to synthetic biology affect public policy?
    Kaebnick GE
    Nat Biotechnol; 2009 Dec; 27(12):1106-8. PubMed ID: 20010586
    [No Abstract]   [Full Text] [Related]  

  • 24. Could bank loans solve Europe's biotech financing slump?
    Mitchell P
    Nat Biotechnol; 2005 Dec; 23(12):1459-60. PubMed ID: 16333276
    [No Abstract]   [Full Text] [Related]  

  • 25. Lessons for the nascent regenerative medicine industry from the biotech sector.
    Mason C; Dunnill P
    Regen Med; 2007 Sep; 2(5):753-6. PubMed ID: 17907927
    [No Abstract]   [Full Text] [Related]  

  • 26. White biotechnology: ready to partner and invest in.
    Kircher M
    Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to turn industrial biotechnology into reality.
    Kircher M
    N Biotechnol; 2012 Jan; 29(2):243-7. PubMed ID: 22100431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Japanese giants renew interest in industrial biotech.
    Sipp D
    Nat Biotechnol; 2005 Mar; 23(3):275-6. PubMed ID: 15765071
    [No Abstract]   [Full Text] [Related]  

  • 29. Biotechnological studies in the Far-Eastern Region of Russia.
    Stonik VA; Mikhailov VV; Bulgakov VP; Zhuravlev YN
    Biotechnol J; 2007 Jul; 2(7):818-25. PubMed ID: 17582826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of private financing hobbles emerging biotech regions.
    Jia H; Jayarama KS; Astvatsaturyan M
    Nat Biotechnol; 2006 Jan; 24(1):7-9. PubMed ID: 16404378
    [No Abstract]   [Full Text] [Related]  

  • 31. Shift toward early-stage deals favors biotechs.
    Lawrence S
    Nat Biotechnol; 2006 Jan; 24(1):6. PubMed ID: 16404377
    [No Abstract]   [Full Text] [Related]  

  • 32. Korean biotechs seize opportunity to list on public markets.
    Louët S
    Nat Biotechnol; 2005 Oct; 23(10):1189-90. PubMed ID: 16211042
    [No Abstract]   [Full Text] [Related]  

  • 33. Hydrocarbons and renewable energy.
    Ringpfeil M
    Nat Biotechnol; 2004 Sep; 22(9):1077. PubMed ID: 15340466
    [No Abstract]   [Full Text] [Related]  

  • 34. Germany biotech gets second chance.
    Sheridan C
    Nat Biotechnol; 2003 Dec; 21(12):1414-5. PubMed ID: 14647310
    [No Abstract]   [Full Text] [Related]  

  • 35. Invention and commercialization in optical bioimaging.
    Farkas DL
    Nat Biotechnol; 2003 Nov; 21(11):1269-71. PubMed ID: 14595349
    [No Abstract]   [Full Text] [Related]  

  • 36. Private biotech 2004--the numbers.
    Hodgson J
    Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enthusiasm cools in Q2.
    Lawrence S
    Nat Biotechnol; 2005 Aug; 23(8):914. PubMed ID: 16082352
    [No Abstract]   [Full Text] [Related]  

  • 38. Public biotech 2006 - the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
    [No Abstract]   [Full Text] [Related]  

  • 39. The way to a powerful business plan.
    Schneider JE
    Drug Discov Today; 2002 Mar; 7(6):342-5. PubMed ID: 11893539
    [No Abstract]   [Full Text] [Related]  

  • 40. Sir Chris Evans divulges his experiences as an entrepreneur. Interview by Rebecca N. Lawrence.
    Evans C
    Drug Discov Today; 2002 Apr; 7(7):399-402. PubMed ID: 11916565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.